Incidence of Kidney Disease

MedPage Today  2 hrs ago  Comment 
(MedPage Today) -- Adding the endothelin receptor antagonist atrasentan to renin-angiotensin blockade reduced albuminuria without major side effects in patients with diabetic nephropathy, researchers found.
DailyFinance  Apr 9  Comment 
Siemens Healthcare and the National Kidney Foundation (NKF) announced today a new strategic alliance focusing on education, awareness and screening for kidney disease in high-risk individuals. This important collaboration will...
Benzinga  Apr 9  Comment 
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") today announced that Phase 2 clinical results of Zerenex™ (ferric citrate coordination complex) in non-dialysis dependent chronic kidney disease (NDD-CKD) patients with elevated serum...
FierceBiotech  Mar 28  Comment 
AstraZeneca has struck up a partnership with the Shenzhen University Health Science Center in Shanghai to collaborate on preclinical work for chronic kidney disease treatments, a growing problem among China's aging population. 
MedPage Today  Mar 28  Comment 
(MedPage Today) -- Diabetics with major depression appear to have an increased risk for kidney failure when compared with those who are not depressed.
DailyFinance  Mar 24  Comment 
ALEXANDRIA, VA -- (Marketwired) -- 03/24/14 -- The American Diabetes Association (Association) is pleased to announce The American Diabetes Association and Boehringer Ingelheim Research Award: Chronic Kidney Disease and Renal Insufficiency...
MedPage Today  Mar 19  Comment 
(MedPage Today) -- Young men with a history of childhood glomerular disease that had resolved were at risk for developing hypertension, an Israeli study showed.
SeekingAlpha  Mar 18  Comment 
By Don Dion: Akebia Therapeutics Inc. (AKBA), a biopharmaceutical firm, focused on the development of novel treatments for anemia, plans to raise $76.0 million in its upcoming IPO. The Cambridge, Massachusetts-based firm will offer 4.9 million...
DailyFinance  Mar 10  Comment 
La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the “Company” or “La Jolla”) today announced positive top-line results from its randomized, placebo-controlled Phase 2 trial of GCS-100 in chronic kidney disease ...
MedPage Today  Mar 5  Comment 
(MedPage Today) -- Among patients with atrial fibrillation and a recent heart attack, warfarin use was associated with improved outcomes -- without excess bleeding -- regardless of the level of kidney function, a Swedish study showed.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki